ConductScience.org, home

Paper688790

Longterm favorable effect of oxygen administration on a patient with primary pulmonary hypertension.

Nagasaka Y and 4 others. Chest, 1978. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. Longterm favorable effect of oxygen administration on a patient with primary pulmonary hypertension. Papers, record 688790. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/688790

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Longterm favorable effect of oxygen administration on a patient with primary pulmonary hypertension.
PubMed
Journal
Chest
PubMed
Year
1978
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
1.43
iCite
Revised in PubMed
2019-05-14
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nagasaka YY
2Akutsu HH
3Lee YSY S
4Fujimoto SS
5Chikamori JJ

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hypertension, PulmonaryMajor topic
Oxygen Inhalation TherapyMajor topic
Adolescent
Female
Humans
Phenoxybenzamine
Time Factors

Source PubMed

Download CSV of topics

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
30942130Effects of oxygen therapy in a pediatric normoxemic patient with pulmonary arterial hypertension and congenital heart disease.Pulm Circ2019https://conductscience.org/library/papers/30942130PubMed
30235299Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension.PLoS One2018https://conductscience.org/library/papers/30235299PubMed
7442300Primary pulmonary hypertension: modern approaches to an old problem.Lung1980https://conductscience.org/library/papers/7442300PubMed
7013775Haemodynamic effects of prostacyclin (PGI2) in pulmonary hypertension.Br Heart J1981https://conductscience.org/library/papers/7013775PubMed
3966945Management of primary pulmonary hypertension.Br Heart J1985https://conductscience.org/library/papers/3966945PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/688790

GET https://conductscience.org/api/papers/v1/688790/authors